Interferon gamma biosimilar (Recpharma)

干扰素γ生物类似药 (Recpharma)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon gamma biosimilar (Recpharma)

Drug Alias Name干扰素γ生物仿制药 (Recpharma)IMMUNEX

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionInterferon gamma receptor stimulantsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsImmunostimulants

TargetsInterferon gamma receptor

Therapy Area/IndicationsGranulomatous Disease, ChronicOsteoporosisNeoplasms +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesRecpharma

China Registration ClassN/A

Active CompaniesRecpharma

Inactive CompaniesN/A

Active IndicationsGranulomatous Disease, ChronicOsteoporosisNeoplasms +[4]

Inactive IndicationsN/A

ATC CodeL03AB03